Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Graeff

Showing results (121-130 of 206) with videos related to

Pageof 21
Sort By:
Biological Chemistry Hoppe-Seyler|July 1, 1992
Tumor-associated urokinase-type plasminogen activator: biological and clinical significanceM Schmitt, F Jänicke, N Moniwa, et al.
Haemostasis|January 1, 1976
Evaluation of hypercoagulability in septic abortionH Graeff, E Ernst, J A Bocaz, et al.
Geburtshilfe Und Frauenheilkunde|August 1, 1990
[Androgenization in postmenopause in rare ovarian tumors--2 case reports]M Kolben, F Jänicke, J Böhm, et al.
Thrombosis Research|May 1, 1977
Incorporation of 125 I-fibrinogen in circulating soluble fibrin monomer complexes during hypercoagulabilityR von Hugo, R Hafter, B Stein, et al.
Histochemistry and Cell Biology|July 29, 1998
Urokinase receptor localization in breast cancer and benign lesions assessed by in situ hybridization and immunohistochemistryR Hildenbrand, W Glienke, V Magdolen, et al.
Klinische Wochenschrift|July 15, 1973
Fibrinogen derivatives with a higher molecular weight than that of the parent molecule in cord vein plasma of newborns. I. Identification in single plasma samplesH Graeff, R von Hugo, W Kuhn, et al.
International Journal of Oncology|September 15, 1998
Thrombomodulin, a receptor for the serine protease thrombin, is decreased in primary tumors and metastases but increased in ascitic fluids of patients with advanced ovarian cancer FIGO IIIcS Wilhelm, M Schmitt, J Parkinson, et al.
Geburtshilfe Und Frauenheilkunde|June 1, 1983
[Markerfunction of crosslinked fibrin derivatives in ascitic fluid from patients with ovarian cancer: a comparison with ascitic fluid in liver cirrhosis]H Graeff, W Klaubert, E Klaubert, et al.
Archives of Gynecology|July 20, 1979
[Circulating fibrin in patients with intravascular coagulation in obstetrics]H Graeff, R Hafter, R von Hugo, et al.
Nucleic Acids Research|October 11, 1995
Inhibition of NF-kappa B-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1U Reuning, O Wilhelm, T Nishiguchi, et al.
Pageof 21

Showing results (121-130 of 206) with videos related to

Sort By:
Pageof 21
Biological Chemistry Hoppe-Seyler|July 1, 1992
Tumor-associated urokinase-type plasminogen activator: biological and clinical significanceM Schmitt, F Jänicke, N Moniwa, et al.
Haemostasis|January 1, 1976
Evaluation of hypercoagulability in septic abortionH Graeff, E Ernst, J A Bocaz, et al.
Geburtshilfe Und Frauenheilkunde|August 1, 1990
[Androgenization in postmenopause in rare ovarian tumors--2 case reports]M Kolben, F Jänicke, J Böhm, et al.
Thrombosis Research|May 1, 1977
Incorporation of 125 I-fibrinogen in circulating soluble fibrin monomer complexes during hypercoagulabilityR von Hugo, R Hafter, B Stein, et al.
Histochemistry and Cell Biology|July 29, 1998
Urokinase receptor localization in breast cancer and benign lesions assessed by in situ hybridization and immunohistochemistryR Hildenbrand, W Glienke, V Magdolen, et al.
Klinische Wochenschrift|July 15, 1973
Fibrinogen derivatives with a higher molecular weight than that of the parent molecule in cord vein plasma of newborns. I. Identification in single plasma samplesH Graeff, R von Hugo, W Kuhn, et al.
International Journal of Oncology|September 15, 1998
Thrombomodulin, a receptor for the serine protease thrombin, is decreased in primary tumors and metastases but increased in ascitic fluids of patients with advanced ovarian cancer FIGO IIIcS Wilhelm, M Schmitt, J Parkinson, et al.
Geburtshilfe Und Frauenheilkunde|June 1, 1983
[Markerfunction of crosslinked fibrin derivatives in ascitic fluid from patients with ovarian cancer: a comparison with ascitic fluid in liver cirrhosis]H Graeff, W Klaubert, E Klaubert, et al.
Archives of Gynecology|July 20, 1979
[Circulating fibrin in patients with intravascular coagulation in obstetrics]H Graeff, R Hafter, R von Hugo, et al.
Nucleic Acids Research|October 11, 1995
Inhibition of NF-kappa B-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1U Reuning, O Wilhelm, T Nishiguchi, et al.
Pageof 21